E-LIB Suche - Ergebnisse für: Piha-Paul, Sarina

1

First-In-Human Phase I Study of Tinengotinib (TT-00420), a ..:

Piha-Paul, Sarina A ; Xu, Binghe ; Dumbrava, Ecaterina E...
The Oncologist. 29 (2024) 4 - p. e514-e525 , 2024

Link: https://doi.org/10.1093/..

2

A Relative Bioavailability, Bioequivalence, and Food Effect..:

Falchook, Gerald ; Patnaik, Amita ; Richardson, Debra L....
Clinical Therapeutics. 46 (2024) 3 - p. 228-238 , 2024

Link: https://doi.org/10.1016/..

3

Initial Chemotherapy for Locally Advanced and Metastatic NU..:

Luo, Jia ; Sanchez, Michelle ; Lee, Elinton...
Journal of Thoracic Oncology. 19 (2024) 5 - p. 829-838 , 2024

Link: https://doi.org/10.1016/..

4

RAF inhibitor re-challenge therapy in BRAF-aberrant pan-can..:

Nelson, Blessie Elizabeth ; Roszik, Jason ; Ahmed, Jibran...
Molecular Cancer. 23 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

5

Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TA..:

Subbiah, Vivek ; Coleman, Niamh ; Piha-Paul, Sarina A....
Cancer Research Communications. 4 (2024) 2 - p. 378-387 , 2024

Link: https://doi.org/10.1158/..

6

Multidisciplinary Care of a Large Brain Metastasis in a Pat..:

Chelariu-Raicu, Anca ; Piha-Paul, Sarina A. ; Chavez-MacGregor, Mariana...
Journal of Immunotherapy and Precision Oncology. 6 (2023) 3 - p. 158-161 , 2023

Link: https://doi.org/10.36401..

7

Selinexor in combination with weekly paclitaxel in patients..:

Westin, Shannon N. ; Fu, Siqing ; Tsimberidou, Apostolia...
Gynecologic Oncology. 168 (2023) - p. 76-82 , 2023

Link: https://doi.org/10.1016/..

8

Impact of Biomarker-Matched Therapies on Outcomes in Patien..:

Carmagnani Pestana, Roberto ; Moyers, Justin T. ; Roszik, Jason...
Clinical Cancer Research. 29 (2023) 9 - p. 1708-1718 , 2023

Link: https://doi.org/10.1158/..

9

A Phase I Trial of Bevacizumab and Temsirolimus in Combinat..:

Nelson, Blessie Elizabeth ; Tsimberidou, Apostolia M ; Fu, Xueyao...
The Oncologist. 28 (2023) 12 - p. 1100-e1292 , 2023

Link: https://doi.org/10.1093/..

10

Antitumour activity of neratinib in patients with HER2-muta..:

Harding, James J. ; Piha-Paul, Sarina A. ; Shah, Ronak H....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

11

BRAF v600E–mutant cancers treated with vemurafenib alone or..:

Nelson, Blessie Elizabeth ; Roszik, Jason ; Janku, Filip...
npj Precision Oncology. 7 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

12

SOLAR: Phase Ib Dose Expansion of Selumetinib (MEK Inhibito..:

Westin, Shannon ; Kurnit, Katherine ; Fellman, Bryan...
Gynecologic Oncology. 176 (2023) - p. S33 , 2023

Link: https://doi.org/10.1016/..

13

Complex I inhibitor of oxidative phosphorylation in advance..:

Yap, Timothy A. ; Daver, Naval ; Mahendra, Mikhila...
Nature Medicine. , 2023

Link: https://doi.org/10.1038/..

14

Predictors of Oncologic Outcome in Patients Receiving Phase..:

Son, Ji ; Lin, Heather Y. ; Fu, Siqing...
Journal of Immunotherapy and Precision Oncology. 6 (2023) 1 - p. 10-18 , 2023

Link: https://doi.org/10.36401..

15

A phase I trial of the pan-ERBB inhibitor neratinib combine..:

Piha-Paul, Sarina A. ; Tseng, Chieh ; Tran, Hai T....
Cancer Chemotherapy and Pharmacology. 92 (2023) 2 - p. 107-118 , 2023

Link: https://doi.org/10.1007/..